Table 3 Details of CRS and HIPEC

PCI [mean (range)]

Total (n=232)

9.3 (0–26)

- Non-ovarian group (n=101)

- Ovarian group (n=131)

- 11.1 (0–25)

- 7.9 (0–26)

Extent of peritonectomy

Total peritonectomy

Disease-specific peritonectomy

49 (21.1%)

183 (78.9%)

Types of CRS

Optimal CRS (CC-0/CC-1)

Suboptimal CRS (CC-2/CC-3)

219 (94.4%)

13 (5.6%)

Multivisceral resections

Hysterectomy/salpingo-oophorectomy

Appendicectomy

Colectomy

Anterior/low-anterior resection

Small intestine -- resection/anastomosis

Splenectomy +/- distal pancreatectomy

Cholecystectomy

Urinary bladder–partial resection

42 (18.1%)

38 (16.4%)

22 (9.5%)

3 (1.3%)

21 (9.1%)

8 (3.5%)

16 (6.9%)

4 (1.7%)

Total

57 (24.5%)

Drugs for HIPEC

Cisplatin

Mitomycin C

Oxaliplatin

Adriamycin

Melphalan

191 (82.3%)

27 (11.6%)

7 (3.0%)

5 (2.2%)

2 (0.9%)

ICU stay

1.3 (1–12) days

Postoperative hospital stay

8.1 (5–26) days